These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 27474734)

  • 1. Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.
    Pitt JM; Vétizou M; Waldschmitt N; Kroemer G; Chamaillard M; Boneca IG; Zitvogel L
    Cancer Res; 2016 Aug; 76(16):4602-7. PubMed ID: 27474734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
    Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
    Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cancer immunotherapy efficacy by gut microbiota.
    Huo S; Liu L; Liu J; Li Q; Wang J
    Discov Med; 2019 Feb; 27(147):93-100. PubMed ID: 30939293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
    Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
    Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the gut microbiota in tumor, immunity, and immunotherapy.
    Xie Y; Liu F
    Front Immunol; 2024; 15():1410928. PubMed ID: 38903520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome in modulating immune checkpoint inhibitors.
    Li X; Zhang S; Guo G; Han J; Yu J
    EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of the Fecal Microbiome on Cancer Immunotherapy.
    Osman AEG; Luke JJ
    BioDrugs; 2019 Feb; 33(1):1-7. PubMed ID: 30604388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome and cancer immunotherapy.
    Sun JY; Yin TL; Zhou J; Xu J; Lu XJ
    J Cell Physiol; 2020 May; 235(5):4082-4088. PubMed ID: 31663125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota in Cancer Immune Response and Immunotherapy.
    Zhou CB; Zhou YL; Fang JY
    Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy.
    Huang J; Jiang Z; Wang Y; Fan X; Cai J; Yao X; Liu L; Huang J; He J; Xie C; Wu Q; Cao Y; Leung EL
    Curr Opin Pharmacol; 2020 Oct; 54():1-10. PubMed ID: 32619934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of intestinal microbiota in the response to anti-tumor therapies].
    Vétizou M; Daillère R; Zitvogel L
    Med Sci (Paris); 2016 Nov; 32(11):974-982. PubMed ID: 28008838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Human Microbiome and Cancer.
    Rajagopala SV; Vashee S; Oldfield LM; Suzuki Y; Venter JC; Telenti A; Nelson KE
    Cancer Prev Res (Phila); 2017 Apr; 10(4):226-234. PubMed ID: 28096237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbiota and immune checkpoint inhibitors.
    Humphries A; Daud A
    Hum Vaccin Immunother; 2018; 14(9):2178-2182. PubMed ID: 29494275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges.
    Bouferraa Y; Chedid A; Amhaz G; El Lakkiss A; Mukherji D; Temraz S; Shamseddine A
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Crosstalk between Microbiome and Immune Response in Gastric Cancer.
    Nasr R; Shamseddine A; Mukherji D; Nassar F; Temraz S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gut microbiota and inflammatory bowel disease.
    Goto Y; Kurashima Y; Kiyono H
    Curr Opin Rheumatol; 2015 Jul; 27(4):388-96. PubMed ID: 26002031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota, the Immune System, and Cytotoxic T Lymphocytes.
    Cosola C; Rocchetti MT; Gesualdo L
    Methods Mol Biol; 2021; 2325():229-241. PubMed ID: 34053062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.